Omnitrust Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$289K Sell
314
-4
-1% -$4.05K 0.37% 41
2025
Q4
$342K Buy
+318
New +$304K 0.43% 37
2025
Q2
$266K Buy
+222
New +$173K 0.31% 51

Other funds holding LLY

Omnitrust Wealth Management's LLY Position: Q1 2026 in Review

Omnitrust Wealth Management reduced its Eli Lilly (LLY) stake by 1.3% in Q1 2026, selling an estimated $4.05K and leaving 314 shares worth $289K. The position accounts for 0.37% of the portfolio, ranked #41.

Omnitrust Wealth Management first reported a position in LLY in Q2 2025 and has held it in 3 quarters since. The position peaked at $342K in Q4 2025. 4,379 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Omnitrust Wealth Management held 314 shares of Eli Lilly worth $289K as of Q1 2026.
  • Omnitrust Wealth Management sold 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up 0.37% of Omnitrust Wealth Management's portfolio in Q1 2026, its #41 holding.
  • Omnitrust Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 3 quarters since.
  • Omnitrust Wealth Management's Eli Lilly position peaked at $342K in Q4 2025.
  • 4,379 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Omnitrust Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.